This document discusses the clinical uses of ultrasonography in twin pregnancies. It covers determining chorionicity and amnioticity, gestational age, screening for anomalies, preterm labor, assessing fetal growth, wellbeing, amniotic fluid, and complications unique to twins such as twin-to-twin transfusion syndrome. Ultrasonography is useful for monitoring growth, detecting anomalies and complications, and guiding management of high-risk twin pregnancies.
Nuchal translucency
It is a sonographic pre natal screening scan to detect cardiovascular abnormality in a fetus.
NT can also detect altered extra cellular matrix composition and limited lymphatic drainage
Nuchal translucency
It is a sonographic pre natal screening scan to detect cardiovascular abnormality in a fetus.
NT can also detect altered extra cellular matrix composition and limited lymphatic drainage
In this presentation we will discuss
First trimester US especially TVS is an integral part for confirmation of intrauterine pregnancy and to rule out ectopic pregnancy.
First trimester US helps us in suggesting conceptus viability.
First trimester US especially TVS is very efficient in approaching and evaluating the cause of vaginal bleeding.
With the use of fertility enhancing medications, advance maternal age pregnancies and just the natural order od twinning, this pregnancy presentation has become more common among providers. Here we explore the etiology, presentation and management of twin pregnancies.
In this presentation we will discuss
First trimester US especially TVS is an integral part for confirmation of intrauterine pregnancy and to rule out ectopic pregnancy.
First trimester US helps us in suggesting conceptus viability.
First trimester US especially TVS is very efficient in approaching and evaluating the cause of vaginal bleeding.
With the use of fertility enhancing medications, advance maternal age pregnancies and just the natural order od twinning, this pregnancy presentation has become more common among providers. Here we explore the etiology, presentation and management of twin pregnancies.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
2. 5. Assessment of fetal growth
6. Assessment of Fetal wellbeing
7. Assessment of amniotic fluid
8. Assessment of umbilical artery
Doppler
9. Diagnosis of rare obstetrical
complications unique to twins
10. Placental localization, and fetal
position for intrapartum
management.
1. Determination of
chorionicity &
amnionicity
2. Determination of
gestational age
3. Screening for
anomalies
4. Screening for PTL
CONTENTS
TYPES
CLINICAL USES OF ULTRASONOGRAPHY
ABOUBAKR ELNASHAR
3. TYPES
1–2% of all pregnancies.
Zygosity:-
2/3rd (Dizygotic) and 1/3rd (Monozygotic).
Chorionicity:-
Dichorionic(80%):- all Dizygotic and 1/3rd of Monozygotic.
Monochorionic (20%):- 2/3rd of Monozygotic
Dizygotic Monozygotic
ABOUBAKR ELNASHAR
5. 1.DETERMINATION OF CHORIONICITY AND
AMNIONICITY
Critical in the management
When?:
1st T.
Why?
1. Management of structural anomalies
2. Screening for aneuploidy,
3. Etiology of fetal growth and/or fluid discordance
4. Early diagnosis of TTT syndrome
5. Management of a surviving twin following
intrauterine demise
ABOUBAKR ELNASHAR
6. {high mortality and morbidity of monoamniotic
twins}: early and intensive monitoring and
intervention: improve outcomes
Before 10 w
sonographic findings to determine chorionicity.
Number of
1. gestational sacs
2. amniotic sacs within the chorionic cavity
3. yolk sacs.
ABOUBAKR ELNASHAR
7. 1. Number of Gestational Sacs
Each gestational sac forms its own placenta and
chorion:
2 gestational sacs: DC twin
1 gestational sac with 2 identified heartbeats: MC
twin
ABOUBAKR ELNASHAR
8. 2. Number of Amniotic Sacs Within the
Chorionic Cavity
Diamniotic twins:
±separate and distinct amnions
{before 10w the separate amnions of a diamniotic
pregnancy will not have enlarged sufficiently to
contact each other and create the inter-twin
septum}.
TAS: {Each single amnion is extremely thin and
delicate: ±very difficult to see
TVS: often successful in differentiating separate
amnions.
ABOUBAKR ELNASHAR
9. 3. Number of Yolk Sacs
2 yolk sacs are seen in the extra-embryonal
coeloma: diamniotic
1 yolk sac
in most cases indicate monoamniotic twins
when there are dual embryos: a follow-up 1st T
scan to definitively assign amnionicity.
ABOUBAKR ELNASHAR
12. After 10 weeks
These sonographic signs are no longer present:
gestational sacs are no longer distinctly separable,
and the inter-twin membrane is formed.
Findings:
(1) Genitalia,
(2) Placental number
(3) Chorionic peak sign
(4) Membrane characteristics.
ABOUBAKR ELNASHAR
13. The following order provides a logical sequence to
determine chorionicity after 10 w.
step 1 is not routinely used at the 10-14 w
1. Sex Discordance
Phenotypic discordance: DC in all but the rarest
cases.
Concordance of phenotype does not rule out
dichorionicity.
ABOUBAKR ELNASHAR
14. 2. Number of Distinct Placentas
1 placental mass: MC
2 distinct, separate placentas: DC
Careful sonographic examination may help
distinguish a single placenta from 2 placentas in
abutment.
ABOUBAKR ELNASHAR
15. 3. Presence or Absence of the Chorionic Peak
(twin peak or lambda sign)
Projecting zone of tissue of similar echotexture to
the placenta
Triangular in cross-section and wider at the
chorionic surface of the placenta, extending into,
and tapering to a point within, the inter twin
membrane.
Most often identifies DC
MC: absence of the twin peak sign.
ABOUBAKR ELNASHAR
16. 4. Inter-Twin Membrane Characteristics
DC :
2 layers of amnion and 2 layers of chorion.
Thicker > 2 mm: PPV: 95%
more reflective
MC:
≤ 2mm: PPV: 90%.
In 2nd T:
Number of membranes may be counted, and if there
are > 2, then dichorionicity is strongly suggested
ABOUBAKR ELNASHAR
20. Dichorionic Diamniotic twin: a triangular projection of
chorionic tissue emanating from fused dichorionic placentas
and extending between layers of the intertwin membrane.
ABOUBAKR ELNASHAR
21. Dichorionic twin in the first trimester: a thick inter twin
membrane
ABOUBAKR ELNASHAR
23. If a membrane is not detected:
careful evaluation to diagnose or exclude
monochorionic monoamniotic twinning
Possibilities:
1. Monoamniotic twinning
2. Twin with complete oligohydramnios (stuck twin)
3. Diamniotic twin pregnancy in which the
membrane is present but not seen
{its thinness and orientation to the transducer}.
ABOUBAKR ELNASHAR
24. The most definitive sonographic finding in the
diagnosis of monoamniotic twins:
Cord entanglement from the placental or umbilical
origin
Colour Doppler may facilitate identification of this
finding.
Entanglement of limbs or observation of a limb
circumscribing the other
Failure to find the membrane between the 2 cord
insertions in the placenta
TVS: is often a helpful adjunct to TAS in identifying
the membrane.
ABOUBAKR ELNASHAR
28. When twin pregnancy is the result of IVF,
accurate determination of gestational
age should be made from the date of embryo
transfer. (II-1A)
To avoid missing a situation of early IUGR in one
twin, most experts agree that the clinician may
consider dating pregnancy using the larger fetus.
(III-C)
ABOUBAKR ELNASHAR
29. 3. SCREENING FOR ANOMALIES
1. Aneuploidy Screening in 1st T
Nuchal transluscency and maternal age.
Using the average NT:
NT in conjunction with maternal age: 75% sensitivity
Useful in the early detection or prediction of TTTS.
An NT threshold at the 95th percentile had a
PPV:43%
NPV: 91%
ABOUBAKR ELNASHAR
30. 2. Aneuploidy Screening in the 2nd T
Soft markers of Down syndrome
Nonossified nasal bone
linear arrangement of the tricuspid and mitral valves within
the heart
thickened nuchal skin fold
slightly short humerus relative to head size
slightly short femur relative to head size
echogenic intracardiac focus
fetal hydronephrosis
ABOUBAKR ELNASHAR
31. If soft markers: fetus-specific risk is calculated
NT thickness correctly identify 5 of 9 Down
syndrome cases
Other markers: less efficacious
Efficacy of 2nd T US: in screening for Down
syndrome in twins: uncertain.
ABOUBAKR ELNASHAR
33. 3. Congenital Malformations
Incidence:
1.2 to 2 times more common in twin.
Dizygotic twins
Rate/fetus is the same as in singletons
Monozygotic twins
rate is 2 to 3 times higher.
The most common structural abnormalities
cardiac
neural tube and brain
facial clefts
gastrointestinal
anterior abdominal wall.
ABOUBAKR ELNASHAR
34. When:
18-22 w (II-2B)
45 minutes for the anomaly scan
ABOUBAKR ELNASHAR
36. 3. Defects or deformities from intrauterine crowding:
foot deformities
hip dislocation
Skull asymmetry
ABOUBAKR ELNASHAR
37. 4. SCREENING FOR PRETERM BIRTH
How:
Cervical length
When:
21-24 w
{correlates highly with PTL at < 32 to 33 w}
Risk of PTL is increased 3- to 5-fold from baseline
prevalence.
PPV: 22% to 38 %.
NPV: high: 94% to 96%.
ABOUBAKR ELNASHAR
38. CL > 35 mm at mid 2nd T: probability of reaching
34-35w is quite high (88% -98%).
Rate of cervical shortening
2.5 mm/w predicted PTL (positive likelihood ratio of 10.8).
Progressive shortening greater than expected
may indicate a higher risk of PTL.
ABOUBAKR ELNASHAR
39. There is still insufficient data to recommend
screening twin pregnancies with TVS cervical
length, but this might change soon!
(Schuit et al. 2014)
ABOUBAKR ELNASHAR
41. 5. ASSESSMENT OF FETAL GROWTH
The growth of twins:
In 1st and 2nd T:
not significantly different from growth of singletons
After 30W:
slower fetal growth
{placental crowding and more frequent anomalous umbilical
cord insertion}.
ABOUBAKR ELNASHAR
42. Growth discordance:
Difference in
1. EFW: range from 15% to 30%
EFW discordance of > 20%.
(SOGC)
2. AC: differences of > 20 mm.
Increased fetal surveillance when:
AC and/or EFW of one or both twins is < 10th
percentile or
Growth discordance
ABOUBAKR ELNASHAR
44. Discordant growth” 20% difference in f weights or
AC difference of > 20 mm
There is a 2.5 cm difference in the AC measurements for twin A
and twin B, indicating 2nd trimester growth discordancy
ABOUBAKR ELNASHAR
45. 6. ASSESSMENT OF FETAL WELLBEING
Frequency:
Monochorionic twin
US/2-3 w, starting at 16-18 w
{early evidence of TTTS}.
Dichorionic twins
/3 w in 3rd T
{growth rate slows down after 30 to 32 w}.
Increased surveillance:
One or both fetuses show growth restriction or discordance.
In these circumstances, serial growth scans/2-3W
(or more frequently in monochorionic twins)
ABOUBAKR ELNASHAR
47. 7. ASSESSMENT OF UMBILICAL ARTERY DOPPLER
{inequality of the 2 fetal-placental circulations can
cause inter-twin differences in growth}: umbilical
artery Doppler velocimetry may improve the
detection of IUGR or fetal growth discordance.
No clear benefit of Doppler velocimetry over the
use of US alone: routine use of Doppler velocimetry
in twin cannot be recommended.
ABOUBAKR ELNASHAR
48. 8. ASSESSMENT OF AMNIOTIC FLUID
Identification of the inter-twin membrane is vital
{determine the fluid space around each fetus}.
Methods:
Subjective
Objective:
Deepest vertical pocket,
Modified amniotic fluid index and
2-dimensional pockets.
ABOUBAKR ELNASHAR
49. Ascertain the presence of fluid, caudal and rostral:
determine to which fetus it belongs and subjectively
estimate if normal.
When AFV reduced or increased: vertical
measurement of the largest pocket in each sac
Oligohydramnios:
deepest vertical pocket < 2 cm
Polyhydramnios:
deepest vertical pocket is > 8 cm.
{These definitions correspond approximately to the 2.5th
percentile and 95th percentile across all gestational ages}.
ABOUBAKR ELNASHAR
50. This is also a common criterion used in defining
TTTS, and for these reasons, this may be the
clinically useful method for assessing
amniotic fluid in twins.
ABOUBAKR ELNASHAR
51. Twin-To-Twin Transfusion Syndrome
Incidence:
15% of MC
Pathology:
In MC placenta: vascular anastamoses.
Superficial and deep.
1) arterioarterial (AA)
2) arteriovenous (AV), or
3) venovenous (VV).
ABOUBAKR ELNASHAR
52. Blood from a donor
twin is transferred to a
recipient twin:
growth-restricted
discordant donor twin
markedly reduced
AF: "stuck."
ABOUBAKR ELNASHAR
53. Diagnosis
LateEarly
1. Polyhydramnios
2. An enlarged fetal bladder
1. Increased NT
2. Abnormal Doppler
of DV
3. Folding of inter twin
membrane can at 16w.
Recipient
1. Oligohydramnios
2. Severe oligohydramnios: amniotic
membrane is closely applied to the
fetus, which lies apposed to the
uterine wall (stuck twin).
3. Bladder can be barely visible
Donor
ABOUBAKR ELNASHAR
54. .
Early
1. Increased NT
Three Fold increase in the risk for
Subsequent development of TTTS .
2. Inter-twin membrane folding
3. Abnormal Doppler of DV of the recipient
ABOUBAKR ELNASHAR
55. Pathognomonic sign:
stuck twin contained within the collapsed inter-twin
membrane {anhydramnios}.
Doppler studies
Umlical a of donor:
Absent or low end diastolic flow
Recipient:
decreased ventricular function depicted by tricuspid
regurgitation, reversal of A wave in ductus venosus,
and/or cardiac chamber enlargement in the recipient
are seen in more advanced stages of TTTS.
ABOUBAKR ELNASHAR
58. Quintero classification
determine the management plan for TTTS.
Stage 1 oligo-polyhydramnios sequence
Stage 2 absent bladder in the donor
Stage 3 abnormal fetal vascular Doppler studies
Stage 4 hydrops of one fetus
Stage 5 death of one fetus
ABOUBAKR ELNASHAR
60. Inter-twin membrane folding
(arrow = dividing membrane)
Polyhydramnios in g sac A
and oligohydramnios in g
sac B (arrow = dividing
membrane)
ABOUBAKR ELNASHAR
65. 9. DIAGNOSIS OF RARE OBSTETRICAL
COMPLICATIONS UNIQUE TO TWINS
Monoamnionicity
Incidence:
1% of all monozygotic twin pregnancies.
Risk:
elevated risk of fetal death
{cord entanglement}.
improved double perinatal survival of 92% when
accurate prenatal diagnosis
serial sonography
antenatal testing
early identification is important
ABOUBAKR ELNASHAR
66. Diagnosis:
First trimester
Predict virtually all cases of monoamniotic twins.
1. Single yolk sac
2. Cord entanglement.
Second trimester:
1. Single shared placenta
2. Fetal phenotype concordance
3. Absence of inter-twin membrane
4. Adequate AF surrounding both fetuses
5. Free movement of both twins within the uterine cavity.
ABOUBAKR ELNASHAR
67. Twin Reversed Arterial Perfusion Syndrome
TRAP sequence, Acardiac twinning
Mechanism
most extreme manifestation of TTTS
umbilical arterial-to-arterial anastomosis
disruption of normal vascular perfusion
ABOUBAKR ELNASHAR
68. Incidence:
1 in 35 000 deliveries
1 in 100 monozyotic twins
1 in 30 monozygotic triplets
Risk:
PTL: 90%
congestive heart failure in the normal twin (also
called pump twin: 30%
Perinatal mortality:
55% in this untreated cohort.
ABOUBAKR ELNASHAR
69. Diagnosis
1. MC twin:
absence of cardiac pulsation
poor definition of fetal parts.
2. Colour Doppler:
reversal of blood flow within the abnormal
fetus.
Blood-flow pattern reveals a paradoxical
direction of arterial flow towards rather than away
from the acardiac twin
retrograde flow in the acardiac twin’s abdominal
aorta.
ABOUBAKR ELNASHAR
73. Differential diagnosis
intrauterine fetal demise
An abnormal monochorionic twin
Placental tumours.
Evaluation:
1. Assess fetal hemodynamic function:
fetal echocardiography
hydrops in the pump twin: poor prognosis
2. Estimation of the weight ratio of the acardiac to
the pump twin
ABOUBAKR ELNASHAR
75. TT:
1. Radio frequency ablation:
pump twin survival rate: 90%.
2. Occlusion of the blood flow to the acardiac twin
by ultrasound-guided diathermy of the umbilical
cord
3. Laser coagulation of the umbilical cord vessels
within the abdomen of acardiac twin, at about 16w
ABOUBAKR ELNASHAR
76. 4. Expectant management
Perinatal survival of the pump twin: 90%
Spontaneous cessation of flow in the acardiac twin
over time: 40%.
Because of the complexity of these cases and
the possible management options, including
expectant management, referral to a tertiary care
unit is indicated.
ABOUBAKR ELNASHAR
77. Conjoined Twins
Definition:-
Incomplete separation of monozygotic twins .
Embryology:-
Incomplete division of the embryonic disk at a
later developmental stage of the blastocyst (at least
13 days after fertilization) in a monozygotic twin
ABOUBAKR ELNASHAR
78. Incidence
1 in 50 000
1 in 100 000 births
1 in 300 monozygotic twin pregnancies.
The recurrence risk is negligible.
Sex ratio:
female > Male (2 : 1).
ABOUBAKR ELNASHAR
79. Classifications:-
according site of connection
1. Thoracopagus (thorax, 30–40%),
2. Omphalopagus (abdomen, 25–30%),
3. Pygopagus (sacrum, 10–20%),
4. Ischiopagus (pelvis 6–20%) .
5. Craniopagus (head, 2–16%).
ABOUBAKR ELNASHAR
80. Diagnosis
1st T.
1. Embryo appears bifid: follow-up imaging should
be performed to confirm the diagnosis.
2. Inability to separate the fetal bodies and skin
contours
3. lack of a separating membrane between the
twins
4. ≥ 3 vessels in the umbilical cord
5. Heads remaining at the same level
6. Body plane, extremities in unusual proximity
7. Failure of the fetuses to change their relative
positions over time.
ABOUBAKR ELNASHAR
81. Prognosis depends on :
• The location and the length of fusion .
• The presence of vital organs: liver and heart
in both twins.
Reasonable chance of survival
only omphalopagus
ABOUBAKR ELNASHAR
82. Single Fetal Death
50% of twin pregnancies identified in 1st T: 2 live
born infants.
Early in pregnancy:
prognosis for the surviving fetus is excellent.
2nd and 3rd T
2% to 5% of twin pregnancie
More common in
MC twins than in DC twins: 3-4 fold higher
HOMP: 14% to 17% of triplet pregnancies.
ABOUBAKR ELNASHAR
85. MCDCSequels of Death of Co-twin
15%3%Fetal Demise
68%54%Preterm Birth
34%16%Abnormal Postnatal Cranial Imaging
26%2%Neuro-developmental Impairment
Management depends on
1. Chorionicity
2. Gestation age
3. Time since death.
ABOUBAKR ELNASHAR
86. Surviving MC twin
Ischemic injury:
in the spleen, kidney, gastrointestinal tract, skin,
and brain
Up to 20%: neurologic injury: multicystic
encephalomalacia.
occur at the time of the demise
These abnormalities may not be diagnosed by US
until much later in pregnancy, far removed from the
ischemic event.
Immediate delivery may not prevent the
development of such complications.
ABOUBAKR ELNASHAR
87. Surviving DC twin
Risk of major perinatal morbidity or mortality:
negligible, apart from the risk related to preterm
delivery.
ABOUBAKR ELNASHAR
88. 1. MC twin
The surviving fetus is at significant risk of
sustaining damage
{sudden, severe, and prolonged hypotension at the
time of the demise or by embolic later}
>34 w: Immediate intervention
32 to 34 W: corticosteroids & delivery after 48H
< 32 w:Conservative management
A. U/S, CTG, BPP
B. if normal: MRI of the fetal brain 2–3 w after
the co-twin death.
C. Counseling should include the long-term
morbidity in this condition
ABOUBAKR ELNASHAR
89. 2. DC
Death of one twin is not a strong indication for
intervention to deliver the surviving twin
A. Expectant management up to 37 w
B. If a condition affecting both twins is present
PET, IUGR: Close surveillance and timely
intervention
C. Regular assessment of coagulation status
ABOUBAKR ELNASHAR
90. Indications for Referral to an appropriate high-
risk pregnancy centre:
1. Twin-to-twin transfusion syndrome
2. Monoamniotic twins gestations
3. Conjoined twins
4. Twin reversed arterial perfusion sequence
5. Single fetal death in the second or third trimester
6. Growth discordance in monochorionic twins.
ABOUBAKR ELNASHAR